Multiple Myeloma Clinical Trials
A listing of Multiple Myeloma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 600 clinical trials
Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma
Selinexor (KPT-330, Xpovio) is a first in class selective inhibitor of nuclear export which has been approved for use in relapsed and refractory multiple myeloma (RRMM). This trial will seek to
- 0 views
- 25 Mar, 2022
- 1 location
RAPA-201 T Cell Therapy for Relapsed, Refractory Multiple Myeloma
RAPA-201-RRMM is an open-label, single-arm, non-randomized multicenter phase II study of RAPA-201 autologous T cells in adults with relapsed, refractory multiple myeloma who have received at
- 1 views
- 25 Mar, 2022
- 1 location
Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma
This study evaluates the safety and efficacy of novel BCMA-targeted CAR-T cell therapy (CBG-002) for patients with relapsed or refractory multiple myeloma (r/r MM). CBG-002 is designed based on
- 0 views
- 15 Apr, 2021
- 1 location
Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients
medication sparing effects in comparison to standard of care management in Multiple Myeloma subjects.
- 0 views
- 24 May, 2022
- 1 location
Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
Evaluate the efficacy and safety of Belantamab Mafodotin, cyclophosphamide, and dexamethasone in patients with Relapsed/Refractory Multiple Myeloma
- 0 views
- 22 Mar, 2022
- 1 location
Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma
with multiple myeloma who have exhausted available treatment options
- 0 views
- 23 Mar, 2022
- 1 location
Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma
populations of CD8+ T cells targeting multiple Myeloma associated antigen peptides in patients with relapsed refractory multiple myeloma (MM). The study will enroll patients with MM who have relapsed
- 0 views
- 27 Jan, 2021
- 4 locations
CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma
This study is aimed to evaluate the safety, feasibility and efficacy of CAR-T cell therapy in the treatment of relapsed or refractory multiple myeloma
- 0 views
- 27 Jan, 2021
- 1 location
A Study of KRN125 in Patients With Multiple Myeloma and Malignant Lymphoma
To determine if KRN125 is non-inferior to filgrastim for the mobilization of hematopoietic stem cells into the peripheral blood in patients with multiple myeloma.
- 0 views
- 09 Jun, 2022
- 21 locations
Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant
This phase II trial studies whether daratumumab and hyaluronidase-fihj and pomalidomide work in treating patients with multiple myeloma that has come back (relapsed) after stem cell transplant
- 2 views
- 03 Feb, 2022
- 1 location